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Hypoxia-inducible factor (HIF) activates the transcription of genes involved in cancer
progression. Recently, HIF was reported to regulate the transcription of non-coding
RNAs. Here, we show that the transcription of a long non-coding RNA (lncRNA), Gastric
Adenocarcinoma Associated, Positive CD44 Regulator, Long Intergenic Non-Coding
RNA (GAPLINC), is directly activated by HIF-1α in gastric cancer (GC). GAPLINC was
overexpressed in GC tissues and promoted tumor migration and invasive behavior.
GAPLINC overexpression was associated with poor prognosis in GC patients. Luciferase
reporter assays and chromatin immunoprecipitation assays confirmed that HIF-1α binds
to the promoter region of GAPLINC and activates its transcription. GAPLINC knockdown
inhibited hypoxia-induced tumor proliferation in vivo. Taken together, our results identified
a novel role for HIF transcriptional pathways in GC tumorigenesis mediated by the
regulation of the lncRNA GAPLINC, and suggest GAPLINC as a novel therapeutic target
for reversing chemoradioresistance and prolonging survival.
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INTRODUCTION
Solid tumor cells are frequently exposed to low levels of oxygen, and activation of hypoxia-related
pathways is a common feature of many types of cancers (Harris, 2002; Pouysségur et al., 2006). Cells
stimulate angiogenesis and metabolic alterations to adapt to hypoxia for survival and progression,
and these changes lead to an aggressive tumor phenotype, resistance to chemotherapy, and poor
clinical outcomes (Nordgren and Tavassoli, 2011).
The human gastric mucosa is exposed to a hypoxic environment (Payne and Bowen, 1981;
Tarnawski et al., 2007), and the extent of hypoxia is obvious in gastric cancer (GC). The hypoxic
microenvironment in the tumor center and aberrant expression of oncogenes facilitate pro-
oncogenic effects (Tarnawski et al., 2007; Matsumoto et al., 2009; Wang et al., 2011). One of the
major factors involved in hypoxic signaling pathways is hypoxia-inducible factor (HIF). HIF-1 is a
heterodimeric transcription factor composed of an α subunit and a β subunit. HIF-1α is the active
subunit of HIF-1 and the predominantmediator of adaptation to hypoxia. It can recognize and bind
to hypoxia response elements (HREs: 5′-A/GCGTG-3′) (Shinohara andMaity, 2009), activating the
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transcription of many genes to mediate pro-oncogenic events
including angiogenesis (Nordgren and Tavassoli, 2011; Li J. et al.,
2014), inflammatory responses (Lee et al., 2014), and growth
factor stimulation (Schito et al., 2012). HIF-1α controls central
metastasis-associated pathways (Branco-Price et al., 2012; Ji,
2014). In GC, HIF-1α exerts a tumorigenic effect by promoting
cell growth, vessel maturation, and cell invasion (Stoeltzing et al.,
2004).
Integrative genomic studies showed that over 10,000 long
non-coding RNAs (lncRNAs) are encoded by the human genome
(Lee, 2012; Batista and Chang, 2013). Despite rapid progress in
screening cancer-related lncRNAs, few lncRNAs associated with
GC have been characterized, including H19 (Li H. et al., 2014),
HOTAIR (Zhang et al., 2015), and ANRIL (Zhang et al., 2014).
GAPLINC, a newly identified 924-bp lncRNA (Hu et al.,
2014) was predicted to contain HREs in the promoter region by
DataBase of Transcriptional Start Sites (DBTSS). It is deregulated
in GC and associated with copy number variations or oncogenic
transcription factors. GAPLINC regulates CD44 as a molecular
sponge for miR-211-3p and enhances tumor migration and
invasion. GAPLINC is therefore considered valuable for the
diagnosis and prognosis prediction of GC.
Here, we investigated the expression of GAPLINC under
conditions of hypoxia and normoxia. We found that GAPLINC
is regulated by hypoxia in the GC cell lines MKN45 and
SGC7901. Hypoxic induction of GAPLINC by HIF-1α leads
to enhanced cell proliferation, migration, and invasion, and
decreased apoptosis. Our results showed that hypoxia-induced
GAPLINC accelerates tumor progression in GC.
MATERIALS AND METHODS
Clinical Specimens
Tissues were obtained from surgical resection in Shengjing
Hospital of China Medical University, including 18 cases of
normal gastric tissues (NGT), 17 cases of highly differentiated
gastric adenocarcinoma (HDAC) tissues, and 16 cases of poorly
differentiated gastric adenocarcinoma (PDAC) tissues. NGTs
were obtained from normal gastric perforation or benign ulcer
surgeries away from the lesion. Tumor specimens were collected
from general gastric cancer radical surgeries. Fresh tissues were
immediately stored in liquid nitrogen after surgical removal. All
patients provided written informed consent. The experiment was
approved by the ethics committee of China Medical University
Shengjing Hospital.
Cell Culture
Human gastric mucosa cell lines GEF-1, HFE-145, human gastric
cancer cell lines MKN45, SGC7901, and human embryonic
kidney cell line HEK-293T were obtained from the Shanghai
Institutes for Biological Sciences Cell Resource Center. HFE-145,
MKN45 cells, and HEK-293T cells were maintained in DMEM
(Thermo Fisher Scientific Inc, MA, USA) containing 10% fetal
bovine serum (FBS, Life Technologies Corporation, Paisley, UK).
SGC7901 and GES-1 cells were cultured in RPMI-1640 (Sigma-
Aldrich, St Louis, MO, USA) containing 10% FBS. Cells were
incubated in a humidified incubator at 37◦C with 5% CO2 in
an atmosphere of either normoxia (21% oxygen), or hypoxia (1%
O2, 5% CO2, and 94% N2 gas mixture) for 24 h.
Plasmid Construction and DNA
Transfection
HIF-1α or HIF-2α subunits were suppressed using siRNAs
(Elvidge et al., 2006). The shRNA against human GAPLINC
(18p11.31) were constructed. MKN45 and SGC7901 cell lines
were transfected with GAPLINC shRNA, and named as
shGAPLINC cells. For the negative control, empty vectors
were used and named as NC. Opti-MEM I and Lipofectamine
3000 reagents (Invitrogen, CA, USA) were used according to
the manufacturer’s instructions. Stable cell lines were created
through the selection by means of Geneticin (G418; Sigma-
Aldrich, St Louis, MO, USA), G418-resistant clones were
obtained after 3–4 weeks. The transfection efficacy was assessed
by quantitative real-time PCR (qRT-PCR).
RNA Extraction and Real-Time
Quantitative PCR
After extraction of total RNA using Trizol (Life Technologies
Corporation), RNA concentration and quality were evaluated by
NanoDrop spectrophotometer (ND-100, Thermo, USA). SYBR
Premix Ex Taq assays of GAPLINC and GAPDH (Applied
Biosystems, Foster City, CA, USA) were used for GAPLINC qRT-
PCR detection. For each assay, a standard curve of threshold
cycle (CT) value vs. log input standard cDNA was constructed.
Fold changes were normalized and calculated using the relative
quantification (2−11Ct) method.
Western Blot Analysis
HIF-1α, HIF-2α content was detected by western blot. Cell
homogenate protein was prepared using loading buffer, RIPA
lysis buffer as well as protease inhibitor (Beyotime Institute of
Biotechnology, Jiangsu, China). Cell homogenate was then boiled
for 5 min. Samples were centrifuged at 17,000 rpm, 4◦C. The
concentrations of proteins were measured using the BCA protein
assay kit (Beyotime Institute of Biotechnology).
Protein samples of interest went electrophoresis and then were
transferred to polyvinylidene fluoridemembrane.Membrane was
blocked in TBST (Tween Tris-buffered saline) buffer containing
5% low fat milk powder, then incubated with primary antibodies
respectively at 4◦C overnight. Primary antibodies included HIF-
1α (diluted at 1:1000, Abcam, Cambridge, UK), HIF-2α (1:500,
Abcam), Bcl-2 (1:2000, Proteintech Group, Chicago, USA),
Bax (1:3000, Proteintech Group), CD44 (1:1000, Proteintech
Group), TGFBR2 (1:500, Abcam), GAPDH (1:5000, Cell
Signaling, Beverly, MA, USA). Then, membranes were incubated
with corresponding HRP-polymerization secondary antibodies
diluted at 1:5000 for 2 h at room temperature. Protein bands were
visualized by ECL detection system, and ChemImager5500V2.03
scanning software. The integrated light density values (IDV) were
calculated with software FluorChem2.0.
Cell Viability Assay
CCK8 reagent (Beyotime institute of biotechnology) and
5-ethynyl-2′-deoxyuridine (EdU) incorporation assay kit (Life
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Technologies Corporation) were used for cell proliferation ability
detection. For CCK8 assay, MKN45 and SGC7901 cells were
seeded in 96 well-plates (Corning, NY, USA) at the logarithmic
growth phase, at a density of 2000/well each group. Two days
later, 10µl of CCK8 reagent was added into the culture medium
and then incubated for 2 h. The absorbance at 450 nm was
recorded.
For EdU incorporation assay, cells were cultured in medium
with 10µMof EdU each well and incubated for 2 h at 37◦C. After
fixing with 4% formaldehyde, cells were incubated with a Click-iT
EdU Kit (Life Technologies Corporation), then stained with
Hoechst 33342 and visualized using a fluorescence microscope
(Olympus, Tokyo, Japan). The EdU incorporation rate was
measured using the ratio of EdU positive cells (green cells)
to total Hoechst 33342 positive cells (blue cells). Scale bar
represented for 20µm.
Cell Apoptosis Assay
Cell apoptosis rate was measured using the Annexin V-PI/FITC
kit (BD Biosciences, NJ, USA). Cells were resuspended into single
cell suspension after washed with ice cold PBS. Then cells were
collected with centrifugation and stained with Annexin V-PI and
FITC for 15 min away from light. After that cells went for flow
cytometry (FACScan, BD) detection, total cells and apoptotic
cells which were stained with fluorescent dye were counted.
Apoptosis ratio was analyzed using BD Accuri C6 software.
Cell Migration and Invasion Assay
In cell migration and invasion assays, the 24-well plates
and transwell chambers with 8 µm size pore polycarbonate
membranes (Corning, NY, USA) were used. Cells were
re-suspended in serum-free medium, and then seeded on the
upper chamber. Matrigel solution (BD, Franklin Lakes, NJ, USA)
was precoated before cell seeding for cell invasion assay. The
serum-containing medium in the 24-well plates induced cells to
migrate and invade. After incubated at 37◦C for 48 h, the cells
on the upper chamber were stripped off with a swab. Then cells
on the lower membrane were fixed with the mixture of glacial
acetic acid andmethanol (3:1), and then stained with 20%Giemsa
solution overnight. Five vision fields were randomly chosen and
cells number was recorded for each well.
Luciferase Reporter Assay
By screening the promoter region of GAPLINC, two binding
motifs (CACGC; Ren et al., 2014 and ACGTG) of HIF-1α were
found. To determine the responsive HIF-1α-binding sites in the
human GAPLINC promoter, promoter activities were measured
using Dual-Luciferase Reporter Assay System. Human full-length
HIF-1α sequence was cloned into pEX3 vector (GenePharma).
pEX3-HIF-1α and its empty vector were transfected into MKN45
and SGC7901 cells. Renilla promoters were co-transfected as
an internal control. Firefly luciferase activity was normalized to
renilla luciferase activity for each individual analysis.
FIGURE 1 | Correlation between HIF-1α protein expression and GAPLINC expression. GAPLINC overexpression was associated with adverse clinical
outcomes in patients with gastric cancer (GC). Data represent the mean ± SD. (A) HIF-1α was highly expressed in human gastric tissues (n = 3 each group). (B) The
endogenous expression of GAPLINC was determined by qRT-PCR in control gastric tissues, highly differentiated gastric adenocarcinoma tissues, and poorly
differentiated gastric adenocarcinoma tissues. (C) Spearman correlation between HIF-1α protein expression and GAPLINC expression (R = 0.6041). (D) GAPLINC
was highly expressed in GCcell lines compared to normal gastric mucosa cell lines. (E) Overall survival (OS) of patients with GAPLINC-low expression (17 cases) and
high expression (16 cases). GAPLINC expressions were normalized to the ratios of expressions in tissues to one specimen picked randomly in NGTs (ranged from
1.23 to 3.24, and the cut off point was 2.03). The Mantel-Cox test was used to compare OS after surgery. The GAPLINC-low expression group had longer OS
(*P < 0.05, **P < 0.01).
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FIGURE 2 | GAPLINC expression was induced under hypoxia mainly by HIF-1α. Data represent the mean ± SD. (A) HIF-1α and HIF-2α were upregulated in
MKN45 and SGC7901 cells under hypoxic conditions. (B) GAPLINC was upregulated under hypoxia in MKN45 and SGC7901 cells. (C) qPCR analysis of the
normoxic expression of GAPLINC in MKN45 and SGC7901 cells following transfection with control siRNA, HIF-1α siRNA, or HIF-2α siRNA. (D) The same experiments
were performed in hypoxia, demonstrating marked dependence on HIF-1α (*P < 0.05, **P < 0.05).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assay was carried out
with Simple ChIP. Enzymatic Chromatin IP Kit (Cell Signaling
Technology, Danvers, Massachusetts, USA). Cells were cross-
linked with 1% paraformaldehyde, and then harvested in lysis
buffer containing phenylmethane sulfonyl fluoride. Chromatin
was cleaved into fragments (200–1000 bps). The 1000 bps
upstream region of the putative HIF-1α binding sites was used as
a negative control in ChIP assay. Lysates (2%) were used as input
control. The rest lysates were immunoprecipitated with normal
mouse IgG or HIF-1α antibody.
The DNA was extracted and amplified by PCR. The forward
and the reverse primers were: PCR1 Forward: 5′-CAACCCT
AATGGGACGTGTTA-3′, Reverse: 5′-CAAACAGAATCACCC
CATGA-3′; PCR2 Forward: 5′-TAATCCCAGCTACTTGGG
AGG-3′, Reverse: 5′-ATTCTTGCCCAGGCTGGAAT-3′, which
covered a potential HRE (hypoxia response elements). The
primers of the control region were: Forward: 5′-GGAAAATAA
AACCATGGAGGG-3′ Reverse: 5′-CGAGATTGAGCCACT
GCACT-3′.
Subcutaneous Xenograft Model in Nude
Mice
For the in vivo study, xenograft experiments were performed
in balb/c nude mice. Mice were purchased from BEIJING HFK
BIOSCIENCE Co. LTD and raised under specific pathogen-
free condition, under the guidance of the laboratory animal
center guideline. All process involving animals was subjected to
approval by the Research Animal Care and Use Committee of
Shengjing Hospital. Cells were subcutaneously implanted into
the right flanks of mice, at density of 1 × 106 cells/mouse. Every
5 days, tumor volumes were measured. Once tumors reached
150 mm3, either bevacizumab (10mg/kg every 3 days) or vehicle
control PBS (Phosphate Buffered Saline) were intraperitoneal
injected to the mice. Tumor volume (mm3)= length×width2/2.
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FIGURE 3 | Knockdown of GAPLINC with shRNAs. (A) Sequence
information of the primers and shRNAs used. (B) Silencing efficiency of
transfection using two shRNAs. The results were derived from at least three
different experiments (*P < 0.05).
Statistical Analysis
All data were presented as means ± standard deviation (SD)
and derived from at least three independent experiments. All
statistical analyses were performed using SPSS 18.0 statistical
software with the Student’s t-test. Probability P < 0.05 was
considered as statistically significant. The spearman rank
correlation test was used for the association between different
variables analyzation. For survival analysis, Mantel-cox test was
used.
RESULTS
HIF-1α and GAPLINC Are Upregulated in
GC Tissues and Cell Lines and Associated
with Poor Patient Prognosis
A recent study reported that the lncRNA GAPLINC is
upregulated in human GC (Hu et al., 2014). Assessment of
HIF-1α expression showed that it was markedly upregulated
under conditions of hypoxia in GC specimens (Figure 1).
Immunoblot analysis showed that HIF-1α was highly expressed
in gastric adenocarcinoma, especially in poorly-differentiated
tumors, compared with NGT (P < 0.05, Figure 1A). qRT-PCR
results showed that the pattern of expression of GAPLINC was
similar to that of HIF-1α (P < 0.05, Figure 1B). Spearman
correlation analysis showed a positive correlation between
GAPLINC and HIF-1α expression (R = 0.6041, P < 0.05,
Figure 1C).We therefore examined the association betweenHIF-
1α and GAPLINC in further detail. GAPLINC was expressed at
higher levels in the GC cell lines MKN45 and SGC7901 than in
the gastric mucosa cell lines GES-1 and HFE-145 (Figure 1D).
Overall survival analysis indicated that GAPLINC overexpression
was associated with poor prognosis in GC patients (P < 0.05,
Figure 1E).
GAPLINC was Upregulated under
Conditions of Hypoxia
Accumulating evidence indicates that the hypoxic
microenvironment provides an important niche for drug-
resistant cells (Brown, 1990; Trédan et al., 2007; Lin et al., 2011).
HIF, as a finely regulated transcriptional factor, could stably
exist in the hypoxic environment in MKN45 and SGC7901 cells
(Figure 2A). To investigate the effect of hypoxia on GAPLINC
expression, GAPLINC levels were monitored under conditions
of normoxia and hypoxia. GAPLINC expression was gradually
upregulated in both cell lines in a hypoxic atmosphere, and after
24 h the difference became significant (Figure 2B, P < 0.01).
Knockdown of the two active subunits of HIF (HIF-1α and
HIF-2α) did not affect GAPLINC expression under normoxia,
whereas GAPLINC was markedly downregulated under hypoxia.
The reduction was more obvious in the siHIF-1α group
(Figures 2C,D).
Hypoxic Induction of GAPLINC Accelerated
Tumor Cell Proliferation, Migration, and
Invasion and Inhibited Cell Apoptosis
The results above prompted us to examine the effect of
the HIF-1α-GAPLINC axis on tumor growth. GAPLINC was
knocked down in MKN45 and SGC7901 cells using two shRNAs
(Figure 3). We next assessed cell proliferation, migration,
invasion, and apoptosis rate. The CCK8 assay was performed out
to examine the functional role of GAPLINC in cell proliferation.
Cells were transfected with GAPLINC shRNA or empty vector.
Under normoxic conditions (Figure 4A), cell proliferation was
decreased in the shGAPLINC group compared with that in the
shGAPLINC-NC group in the MKN45 and SGC7901 cell lines
(P< 0.05). This suggested that GAPLINC is a carcinogenic factor
involved in regulating GC viability. Under hypoxia, the viability
of GC cells was inhibited; however, the shGAPLINC group
showed a lower survival rate than the shGAPLINC-NC group
(P < 0.01), suggesting that GAPLINC plays an important role in
sustaining cell survival under hypoxia. EdU incorporation assay
results supported this phenomenon (Figure 4B). The proportion
of positive cells (green) among total cells (blue) represented
the mitotic cell population. Positive cell numbers were lower in
shGAPLINC groups than shGAPLINC-NC groups (P < 0.05).
GAPLINC played a vital role in inhibiting cell apoptosis
according to the cell apoptosis assay (Figure 4C). The
shGAPLINC groups showed higher apoptosis rates than
the shGAPLINC-NC groups under normoxia or hypoxia. Under
hypoxic conditions, GAPLINC knockdown resulted in more cell
death in MKN45 cells (P < 0.01).
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FIGURE 4 | GAPLINC sustained tumor cell growth and decreased cell apoptosis in MKN45 and SGC7901 cells especially under hypoxic conditions.
Values represent the mean ± SD. (A) Cell proliferation rates detected using CCK8 reagents. (B) EdU incorporation assay (C) AnnexinV PI/FITC staining in normoxic
and hypoxic MKN45 and SGC7901 cells treated with either control or shGAPLINC showing reduced proliferation, reduced DNA replication and increased apoptosis
following GAPLINC depletion. The effect was more obvious under hypoxia (*P < 0.05, **P < 0.05).
The cell migration and invasion assays showed similar
results (Figures 5A–D and Figure S1). GAPLINC knockdown
attenuated cell mobility in 12 and 48 h after seeding. According
to the results, cell migration and invasion abilities relied more on
GAPLINC under hypoxia than normoxia. These results clearly
revealed that GAPLINC could sustain cell survival especially
under poor aerobic conditions.
HIF-1α Transcriptionally Activated
GAPLINC
We speculated that there may be a direct interaction between
GAPLINC and HIF-1α, the most important factor induced by
hypoxia. HIF-1α binds the “ACGTG”motif according to JASPAR
prediction (Figure 6A) and the “CACGC” sequence (Ren et al.,
2014), which is characteristic of hypoxic response elements.
Screening of the promoter region of GAPLINC identified
two potential binding regions for HIF-1α (−320/−324 and
−578/−582). To further investigate the mechanism underlying
the HIF-1α mediated regulation of GAPLINC expression, a
luciferase assay was performed (Figure 6B). The position of
the transcription start site (TSS) was predicted by DBTSS.
Putative and wild-type HIF-1α binding sites were constructed.
Cotransfection with pEX3-HIF-1α resulted in the activation of
the GAPLINC promoter containing two HREs by 4.3- and
3.7-fold in MKN45 and SGC7901 cells, respectively. For the
GAPLINC promoter containing one HRE, the activation was 2.5-
and 2.8-fold in MKN45 and SGC7901 cells, respectively.
To confirm that HIF-1α binds to the HREs of the GAPLINC
promoter, a ChIP assay was performed (Figure 6C). Pull down
with an anti-HIF-1α antibody identified the PCR fragments
of two HREs in the GAPLINC promoter. No PCR fragment
was detected in samples pulled down by control IgG antibody.
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FIGURE 5 | GAPLINC promoted tumor cell migration and invasion abilities of MKN45 and SGC7901 cells especially under hypoxic conditions. Values
represent the mean ± SD. (A,B) Cell migration abilities under nomoxia and hypoxia. (C,D) Cell invasion abilities under nomoxia and hypoxia (*P < 0.05, **P < 0.05).
No interaction with the negative control region was observed.
Taken together, the results of luciferase and ChIP assays
demonstrated that HIF-1α could bind to the GAPLINC promoter
and upregulate the promoter activities in human MKN45 and
SGC7901 cells.
GAPLINC Affected Apoptotic and Motility
Related Proteins and was Induced by
Hypoxia in Xenograft Tumors
Despite reports that GAPLINC increases GC invasiveness by
rescuing CD44 from miR-211, we next examined functional
proteins related to tumor growth and invasiveness. Since
GAPLINC can absorb miR-211, which increases Bcl-2,
and Bcl-2 abrogation upregulates the apoptotic protein
Bax, Bcl-2, and Bax expressions were detected. As shown
in Figure 7A, GAPLINC ablation upregulated Bcl-2,
increased the CD44 content, and downregulated Bax in
MKN45 and SGC7901 cells under hypoxia (P < 0.05). This
could partly account for the phenomenon that GAPLINC
rescues cell viability and invasiveness under poor oxygen
conditions.
To further confirm the hypoxic induction of GAPLINC, an
in vivo xenograft model was used. Nude mice were raised under
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FIGURE 6 | HIF-1α bound to the HRE of GAPLINC and triggered transcriptional activation. (A) The binding motif of HIF-1α transcription pathway. (B) Effect of
HIF-1α on the promoter activities of GAPLINC in MKN45 and SGC7901 cells. Schematic depiction of the different reporter constructs (a and b) used and the luciferase
activity. Plasmid activity after normalization with the co-transfected reference vector pRL-TK is shown in the X-axis. Background luminescence from cells transfected
with empty pGL3-basic vector was substracted from the sample readings. (C) The ChIP assay indicated that HIF-1α binds to the GAPLINC promoter in MKN45 and
SGC7901 cells. Transcription start site (TSS) and putative HIF-1α binding sites are indicated. Immunoprecipitated DNA was amplified by PCR. Normal rabbit IgG was
used as a negative control. Visualized bands were considered as positive results and indicated endogenous binding of HIF-1α to DNA fragments (*P < 0.05).
pathogen free condition, and then MKN45 and SGC7901 cells
were inoculated at a density of 106 subcutaneously. Cells then
grew as xenografts. Mice were treated with either bevacizumab
to increase tumor hypoxia or PBS as vehicle control (Choudhry
et al., 2015). As shown in Figure 7, bevacizumab administration
upregulated GAPLINC RNA levels in xenografts derived from
both MKN45 and SGC7901 cells. As a positive control, HIF-1α
levels were measured in xenograft tumors from both cell
lines. HIF-1α protein levels were increased after bevacizumab
treatment along with GAPLINC. Taken together, these results
indicated that GAPLINC was induced by hypoxia both in vivo
and in vitro.
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FIGURE 7 | GAPLINC regulated tumor-related proteins under hypoxia
and their levels were increased in solid tumors under simulated
hypoxic conditions. (A) GAPLINC ablation upregulated Bcl-2, CD44, and
TGFBR2 and downregulated Bax in MKN45 and SGC7901 cells under
hypoxia (*P < 0.05 vs. the respective control group). (B) Nude mice were
treated with the anti-angiogenesis agent bevacizumab or vehicle only. HIF-1α
was induced in tumor xenografts treated with bevacizumab. (C) GAPLINC
expression was upregulated in the bevacizumab group compared with the
PBS groups (*P < 0.05, **P < 0.05).
DISCUSSION
A considerable amount of evidence supports that aberrant
expression of lncRNAs is not only involved in the regulation of
the eukaryotic genome, but also plays a role in tumor malignancy
(Prensner and Chinnaiyan, 2011; Ling et al., 2015; Zhao et al.,
2015). The genes with causal roles in GC are usually copy
number variations or oncogenic transcription factors (Deng et al.,
2012). As a result, tumors are more invasive and uncontrolled.
The lncRNA GAPLINC functions as an endogenous molecular
sponge by binding to miR-211 with the putative miRNA response
element to form a RNA-induced silencing complex (RISC). As a
result, CD44 expression is upregulated because of the reduction
of free miR-211-3p, which targets CD44 for degradation (Hu
et al., 2014). Our research supports a previous report showing
that GAPLINC is highly expressed in GC and involved in the
pathogenesis of the disease. In the present study, we showed that
GAPLINC increased cell viability and decreased cell apoptosis,
suggesting that GAPLINC levels are critical for GC cell growth.
GAPLINC promoted cell viability and inhibited cell death
under normoxia. Under conditions of hypoxia, GAPLINC
strongly promoted cell survival. miR-211, which functions
downstream of GAPLINC, downregulates the anti-apoptotic
factor Bcl-2 (De Luca et al., 2015). In the present study,
knockdown of GAPLINC downregulated Bcl-2 and upregulated
Bax. The Bcl-2/Bax ratio, which is described as the “molecular
switch” of apoptosis regulation, is the hub of cell death (Chao and
Korsmeyer, 1998). GAPLINC silencing decreased theBcl-2/Bax
ratio, leading to increased cell death.
Because previous work in normoxia showed that gastric cell
migration and invasion abilities are enhanced by GAPLINC, we
confirmed that GAPLINC is essential for cell motility under
poor oxygen conditions. To exclude the effect of cell number
decrease due to apoptosis, we analyzed cell migration and
invasion abilities 12 h after seeding (Figure S1). The trend was
similar with Figure 5. The attenuation of cell mobility could be
partly attributed to the fact that increased GAPLINC can capture
miR-211 to rescue CD44 indirectly. CD44 positivity is associated
with higher cell mobility, invasiveness, and shorter tumor-free
survival, and it promotes themaintenance of stemness in GC cells
(Cho et al., 2015). A CD44-SLC1A2 fusion transcript resulting
from a paracentric chromosomal inversion establishes a pro-
oncogenic metabolic milieu and produces a subtype of chemo-
resistant GC cells (Tao et al., 2011).
Generally, solid tumors are characterized by hypoxia in the
tumor center, which provides a poor cellular microenvironment
with low pH and inadequate supply of nutrients (Pouysségur
et al., 2006). Hypoxia in most solid tumors results in an
aggressive and invasive phenotype (Ji, 2014) and stem cell-
like characteristics (Kim et al., 2009; Zhang et al., 2012).
This is partly responsible for resistance to chemotherapy and
radiotherapy (Semenza, 2004). Increasing evidence indicates that
the expression of certain lncRNAs changes during hypoxia (Yang
et al., 2013; Gómez-Maldonado et al., 2015). One outstanding
example is lncRNAEFNA3, which is induced by hypoxia and
promotes GC cell metastasis and dissemination.
Since the hypoxic condition in GC is general, we explored
the regulation and function of GAPLINC under hypoxia.
Evidence suggests that some lncRNAs are involved in the HIF
transcriptional regulation pathway. NEAT1 is transcriptionally
activated by HIF-2 to form nuclear speckles (Choudhry et al.,
2015). In the present study, we showed that GAPLINC is
upregulated in response to low oxygen, and the modulation of
GAPLINC expression was confirmed in vivo in the nude mice
xenograft models. The anti-angiogenesis drug bevacizumab is
used to imitate poor oxygenation conditions, and changes inHIF-
1α protein levels indicate hypoxia simulation. We performed
qRT-PCR and showed that GAPLINC was upregulated in
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xenografts of both cell lines. This suggested that GAPLINCis
regulated by HIFs. Compared with its expression under
normoxia, GAPLINC was downregulated by HIF-1α or HIF-2α
ablation under conditions of hypoxia, and HIF-1α knockdown
had a greater effect than HIF-2α knockdown. A ChIP assay
demonstrated direct binding of HIF-1α to the HREs in MKN45
and SGC7901 cells. Furthermore, a luciferase assay provided
supports for the transcriptional regulation. These data indicate
that GAPLINC is induced under hypoxic conditions as a target
of HIF-1α. In a previous study, HIF-1α was shown to induce
GC glycolysis and cell proliferation (Liu et al., 2016); the present
study provides additional information about the GC micro
environment.
Knockdown of GAPLINC had a greater effect on cell survival
and dissemination under hypoxia than under nomoxia. This
could be attributed to the fact that GAPLINC is produced in
response to stress signals, and knockdown of GAPLINC under
hypoxia will lead to a more significant decrease of GAPLINC.
Tumor angiogenesis is essential for the growth of tumors
by increasing the delivery of nutrients and oxygen. Therefore,
anti-angiogenesis therapy has become a clinical strategy in line
with traditional therapies (Ma and Adjei, 2009; Burger et al.,
2011). Chemotherapy combined with anti-angiogenesis drugs
such as ramucirumab (Javle et al., 2014; Mackey et al., 2015) and
apatinib (Li et al., 2013) has shown efficacy in the treatment of
advanced metastatic GC. However, hypoxia tolerant cells result
in poor treatment effects and prognosis (Bottsford-Miller et al.,
2012; Jain, 2014). Therapy targeting HIF and its key downstream
signaling pathway may partly reverse this outcome. The present
study identified a novel target of the HIF pathway in gastric
adenocarcinoma. Our in vitro and in vivo data demonstrate that
GAPLINC contributes to the aggressive phenotype of tumors
showing tolerance to hypoxia. These results suggest potential
novel therapies, such as gene therapy targeting HIF-1α and
GAPLINC. Although, additional studies are needed for the
potential clinical application of these strategies, this pathway
should be investigated further to provide new options for the
treatment of GC.
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